Policy Notices

• Notice to Extend PA-20-028, Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18)
  (NOT-HS-22-020)
  Agency for Healthcare Research and Quality
  

• Notice to Extend PA-18-793
  (NOT-HS-22-021)
  Agency for Healthcare Research and Quality
  

General Notices

• Notice of Pre-Application Webinar for Cancer Prevention and Control Clinical Trials Planning Grant Program (PAR-22-173 (R34) and PAR-22-174 (U34))
  (NOT-CA-22-115)
  National Cancer Institute
  

• Notice of NIDCR Participation in RFA-CA-22-040, The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
  (NOT-DE-22-014)
  National Institute of Dental and Craniofacial Research
  

• Notice for the NIGMS Grant Writing Webinar Series for Institutions Building Research and Research Training Capacity
  (NOT-GM-22-041)
  National Institute of General Medical Sciences
  

• Notice of NICHD Participation in NOT-MH-20-110, Collaborative Research in Computational Neuroscience (CRCNS) NSF Innovative Approaches to Science and Engineering Research on Brain Function"
  (NOT-HD-22-027)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NHLBI Participation in PAR-21-252 "Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)"
  (NOT-HL-22-037)
  National Heart, Lung, and Blood Institute
  

• Notice of NHLBI Participation in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)"
  (NOT-HL-22-038)
  National Heart, Lung, and Blood Institute
  

• Notice to Extend Expiration Date for PAR-20-283: NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed).
  (NOT-LM-22-001)
  National Library of Medicine
  

• Notice of Informational Webinar for NINDS Interdisciplinary Team Science RM1 Funding Opportunity Announcement
  (NOT-NS-23-019)
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of Change to Applications and Submission Information for RFA-AR-23-001, "Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)"
  (NOT-AR-23-003)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Extension of PAR-20-299, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
  (NOT-HD-22-030)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Extension of PAR-20-300, "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
  (NOT-HD-22-031)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD Participation in RFA-DA-23-051 HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)
  (NOT-HD-22-037)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Change to the maximum salary for clinician-scientists for PAR-21-153 and PAR-21-234 NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01)
  (NOT-NS-22-107)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to the maximum salary for clinician-scientists for PAR-21-327 and PAR-21-328 Career Transition Award for NINDS Intramural Clinician-Scientists (K22)
  (NOT-NS-22-108)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to the Maximum Salary for Clinician-Scientists for PAR-22-022 NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00)
  (NOT-NS-22-109)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction to Announcement Type for "PAR-22-142: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)"
  (NOT-NS-22-120)
  National Institute of Neurological Disorders and Stroke
  

• Notification to the community of change in maximum salary provided by NINDS K award mechanisms for clinician-scientists.
  (NOT-NS-23-005)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed)
  (NOT-DE-22-013)
  National Institute of Dental and Craniofacial Research
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Multisite Clinical Trials: Leveraging Network Infrastructure to Advance Research and Outcomes for Women, Children, Pregnant and Lactating Individuals and/or Persons with Disabilities
  (NOT-HD-22-028)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Intent to Publish a Funding Opportunity Announcement for ClinGen Genomic Curation Expert Panels (U24 Clinical Trial Not Allowed)
  (NOT-HD-22-036)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional)
  (NOT-MH-22-280)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain(RM1 Clinical Trial Optional)
  (NOT-NS-23-009)
  National Institute of Neurological Disorders and Stroke
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not Allowed)
  (NOT-OD-22-188)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Promoting Mechanistic Research on Therapeutic and Other Biological Properties of Minor Cannabinoids and Terpenes
  (NOT-AT-22-027)
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  Office of Dietary Supplements
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Administrative Supplements to Support Extramural Collaborators for Notified Applicants for the Bench-to-Bedside and Back Program (BtB) (Clinical Trial Optional)
  (NOT-OD-22-185)
  Office of the Director, NIH
  

Funding Opportunities

• Geroscience Course (R25 Independent Clinical Trial Not Allowed)
  (PAR-22-214)
  National Institute on Aging
  Office of Dietary Supplements
  Application Receipt Date(s): October 21, 2022
  
  

• Biology of Bladder Cancer (R01 Clinical Trial Optional)
  (PAR-22-218)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2025
  
  

• Biology of Bladder Cancer (R21 Clinical Trial Optional)
  (PAR-22-219)
  National Cancer Institute
  Application Receipt Date(s): September 07, 2025
  
  

• Cellular and Molecular Mechanisms of Prion-Like Aggregate Seeding, Propagation, and Neurotoxicity in AD/ADRD (R01 Clinical Trial Not Allowed)
  (PAR-23-023)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): October 24, 2022
  
  

• NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
  (RFA-CA-22-045)
  National Cancer Institute
  Application Receipt Date(s): November 07, 2024
  
  

• HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required)
  (RFA-DA-23-048)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Disease Prevention
  Application Receipt Date(s): November 08, 2022
  
  

• HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)
  (RFA-DA-23-049)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Mental Health
  Application Receipt Date(s): February 02, 2023
  
  

• Helping to Accelerate Research Potential (HARP) (UE5 - Clinical Trial Not Allowed)
  (RFA-DK-22-002)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 30, 2022
  
  

• Interventions that Address Structural Racism to Reduce Kidney Health Disparities - (U01 - Clinical Trial Required)
  (RFA-DK-22-014)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Disease Prevention
  Application Receipt Date(s): November 17, 2022
  
  

• Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
  (RFA-DK-22-015)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Disease Prevention
  Application Receipt Date(s): November 17, 2022
  
  

• Integrated Physiology of Exocrine and Endocrine Pancreas in Type 1 Diabetes (R01 - Clinical Trial Not Allowed)
  (RFA-DK-22-022)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 21, 2023
  
  

• Academic Development of a Training Program for Good Laboratory Practices in High Containment Environments (U24) Clinical Trials Not Allowed
  (RFA-FD-23-002)
  Food and Drug Administration
  Application Receipt Date(s): October 03, 2022
  
  

• Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2023 (R24 Clinical Trial Not Allowed)
  (RFA-HD-23-027)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): December 02, 2022
  
  

• NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
  (RFA-MH-22-185)
  National Institute of Mental Health
  Application Receipt Date(s): June 20, 2025